Integrated Filing — IndAS



General information about company

Scrip Code 524037
NSE Symbol RAMAPHO
MSEI Symbol NOTLISTED
ISIN INE809A01032
Name of company RAMA PHOSPHATES LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 13-11-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 05-11-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 13-11-2026   11:00:00
End date and time of board meeting 13-11-2026   12:55:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 14-05-2025
Indicate Company website link for updated RPT policy of the Company www.ramaphosphates.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
No default on Loan by the Company



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 29,551.48 52,031.07
Other income 22.78 98.03
Total income 29,574.26 52,129.10
2 Expenses
(a) Cost of materials consumed 18,840.72 35,976.27
(b) Purchases of stock-in-trade 1,270.30 1,278.64
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 1,648.89 (889.58)
(d) Employee benefit expense 863.54 1,811.75
(e) Finance costs 392.42 797.65
(f) Depreciation, depletion and amortisation expense 180.89 359.71
(f) Other Expenses
1 Other Expenses 3,753.58 7,889.51
Total other expenses 3,753.58 7,889.51
Total expenses 26,950.34 47,223.95
3 Total profit before exceptional items and tax 2,623.92 4,905.15
4 Exceptional items 0.00 0.00
5 Total profit before tax 2,623.92 4,905.15
6 Tax expense
7 Current tax 735.06 1,308.71
8 Deferred tax (27.90) (26.76)
9 Total tax expenses 707.16 1,281.95
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 1,916.76 3,623.20
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 1,916.76 3,623.20
17 Other comprehensive income net of taxes (11.65) (16.78)
18 Total Comprehensive Income for the period 1,905.11 3,606.42
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1,767.43 1,767.43
Face value of equity share capital 5 5
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 5.42 10.24
Diluted earnings (loss) per share from continuing operations 5.42 10.24
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 5.42 10.24
Diluted earnings (loss) per share from continuing and discontinued operations 5.42 10.24
24 Debt equity ratio 0.4100 0.4100
25 Debt service coverage ratio 4.6100 4.6100
26 Interest service coverage ratio 7.6900 7.1500
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1. The above results have been reviewed by the Audit Committee and were taken on the record by the Board at their Board meeting held on 13th November, 2026. The Statutory Auditor has carried out a Limited Review of the Unaudited Financial Result for the quarter & Half year ended 30th September, 2026. 2. The above results are prepared in compliance with Indian Accounting Standard (Ind-AS) as prescribed under Section 133 of the Companies Act, 2013 and notified by the Ministry of Corporate Affairs under the Companies (Indian Accounting Standards) Rules, 2015 & amendments issued thereafter and other accounting principles generally accepted in India. 3. The Company does not have any Subsidiary company or Associate company or Joint Venture company, as on 30th September, 2026 and consequently the Company is not required to prepare consolidated financial results as per applicable laws and regulations. 4. A) The Company is focused on two business segments: Fertilizers, Micro Nutrients & Chemicals and Soya/Agri. Based on the management approach as defined in Ind AS 108 - 'Operating Segments', the Chief Operating Decision Maker evaluates the Company's performance and allocates resources based on an analysis of various performance indicators by business segments. Accordingly, information has been presented along these business segments. The accounting principles used in the preparation of the financial results are consistently applied to record revenue and expenditure in individual segments. B) Segment results represents the profit/(loss) before interest and Tax charged by each segment without allocation of central administrative costs, finance cost and other income. 5.Tax, including Deferred Tax is accounted based on quarterly results and difference, if any, will be adjusted in the last quarter for annual tax/deferred tax. 6. The Company has successfully commenced trial production of Single Super Phosphate (SSP) fertilizer on 11th November 2026 under Phase I of its greenfield manufacturing facility located at the MIDC Industrial Area, Nardana, Dhule, Maharashtra. The Company expects to initiate full-scale actual commercial production shortly after receiving requisite approvals from appropriate statutory authorities. With the commencement of operations at the new facility, the Company's total aggregate SSP production capacity stands at 9.14 lakh (MTPA). Moreover, activities under Phase II have also started. 7. The Board of Directors have recommended an interim dividend of Rs 0.50 per Equity share (10% on face value of Rs. 5/- share). 8. The results of the Company are also available on stock exchange websites www.nseindia.com, www.bseindia.com and on the Company website at (www.ramaphosphates.com). 9. The Company has a long-term credit rating of A- by ICRA. 10. Figures of the previous quarter/period have been regrouped/rearranged, wherever necessary to make them comparable.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 15,501.60
Capital work-in-progress 6,948.04
Investment property
Goodwill 0.00
Other intangible assets 69.94
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 36.94
Trade receivables, non-current
Loans, non-current 0.00
Other non-current financial assets
1 Other financial assets 431.05
Total of other non-current financial assets 431.05
Total non-current financial assets 467.99
Deferred tax assets (net)
Other non-current assets
1 Other non-current assets 6.54
Total of other non-current assets 6.54
Total non-current assets 22,994.11
2 Current assets
Inventories 21,777.71
Current financial asset
Current investments 0.00
Trade receivables, current 8,440.11
Cash and cash equivalents 13.95
Bank balance other than cash and cash equivalents 1,389.14
Loans, current 19.84
Other current financial assets
Total of other current financial assets 16,754.58
Total current financial assets 26,617.62
Current tax assets (net)
Other current assets
1 Other current assets 7,394.79
Total of other current assets 7,394.79
Total current assets 55,790.12
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 78,784.23
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,767.43
Other equity 44,063.59
Total equity attributable to owners of parent 45,831.02
Non controlling interest
Total equity 45,831.02
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 2,026.40
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
Total of other non-current financial liabilities
Total non-current financial liabilities 2,026.40
Provisions, non-current 145.60
Deferred tax liabilities (net) 1,496.41
Deferred government grants, Non-current
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 3,668.41
Current liabilities
Current financial liabilities
Borrowings, current 16,742.37
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 2,213.77
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 5,968.00
Total Trade payable 8,181.77
Other current financial liabilities
1 Lease Liabilities 68.43
2 Other financial liabilities 1,821.26
Total of other current financial liabilities 1,889.69
Total current financial liabilities 26,813.83
Other current liabilities 1,141.96
1 Other current liabilities 1,141.96
Total of other current liabilities 1,141.96
Provisions, current 339.35
Current tax liabilities (Net) 989.66
Deferred government grants, Current 0.00
Total current liabilities 29,284.80
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 32,953.21
Total equity and liabilites 78,784.23
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Fertilizers, Micro Nutrients & Chemicals 29,426.97 51,549.68
2 Soya/Agri 0.0012451 0.0048139
Total Segment Revenue 29,551.48 52,031.07
Less: Inter segment revenue
Revenue from operations 29,551.48 52,031.07
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Fertilizers, Micro Nutrients & Chemicals 3,258.18 6,125.64
2 Soya/Agri (27.76) (55.94)
Total Profit before tax 3,230.42 6,069.70
i. Finance cost 392.42 797.65
ii. Other Unallocable Expenditure net off Unallocable income 214.08 366.90
Profit before tax 2,623.92 4,905.15
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Fertilizers, Micro Nutrients & Chemicals 75,165.83 75,165.83
2 Soya/Agri 2,575.78 2,575.78
Total Segment Asset 77,741.61 77,741.61
Un-allocable Assets 1,042.62 1,042.62
Net Segment Asset 78,784.23 78,784.23
4 Segment Liabilities
Segment Liabilities
1 Fertilizers, Micro Nutrients & Chemicals 29,492.01 29,492.01
2 Soya/Agri 298.26 298.26
Total Segment Liabilities 29,790.27 29,790.27
Un-allocable Liabilities 3,162.94 3,162.94
Net Segment Liabilities 32,953.21 32,953.21
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement gain/(loss) on defined benefit plan (1.15) (10.43)
2 Gain / (Loss) on Fair Value of Investments (12.59) (10.47)
Total Amount of items that will not be reclassified to profit and loss (13.74) (20.90)
2 Income tax relating to items that will not be reclassified to profit or loss (2.09) (4.12)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income (11.65) (16.78)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 4,905.15
Adjustments for reconcile profit (loss)
Adjustments for finance costs 794.47
Adjustments for decrease (increase) in inventories (368.63)
Adjustments for decrease (increase) in trade receivables, current (1,235.70)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (1,711.95)
Adjustments for decrease (increase) in other non-current assets (0.02)
Adjustments for other financial assets, non-current 47.27
Adjustments for other financial assets, current (1,975.49)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (2,886.41)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (109.35)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 359.71
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 16.60
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 430.26
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 87.01
Adjustments for dividend income 0.00
Adjustments for interest income 93.77
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) (32.41)
Other adjustments for non-cash items 0.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (6,678.41)
Net cash flows from (used in) operations (1,773.26)
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 141.98
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities (1,915.24)
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 0.00
Purchase of property, plant and equipment 2,232.28
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 174.68
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 93.77
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (253.96)
Net cash flows from (used in) investing activities (2,217.79)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 5,048.11
Repayments of borrowings 0.00
Payments of lease liabilities 0.00
Dividends paid 22.12
Interest paid 791.93
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (102.53)
Net cash flows from (used in) financing activities 4,131.53
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (1.50)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (1.50)
Cash and cash equivalents cash flow statement at beginning of period 15.45
Cash and cash equivalents cash flow statement at end of period 13.95





Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Rama Phosphates Limited Rama Industries Ltd Entities with joint control or significant influence over entity Any other transaction Loan Taken Approved by Audit Committee 840.00 0.00 0.00 Loan 9.00 180 days Unsecured Working Capital Requirement
2 Rama Phosphates Limited Rama Industries Ltd Entities with joint control or significant influence over entity Any other transaction Loan Repaid Approved by Audit Committee 840.00 0.00 0.00 Loan 9.00 180 days Unsecured Working Capital Requirement
3 Rama Phosphates Limited Rama Industries Ltd Entities with joint control or significant influence over entity Interest paid Approved by Audit Committee 6.14 0.00 0.00
4 Rama Phosphates Limited TRISHUL MERCANTILE PVT LTD Entities with joint control or significant influence over entity Any other transaction Loan Taken Approved by Audit Committee 980.00 0.00 680.00
5 Rama Phosphates Limited TRISHUL MERCANTILE PVT LTD Entities with joint control or significant influence over entity Any other transaction Loan Repaid Approved by Audit Committee 300.00 0.00 0.00
6 Rama Phosphates Limited TRISHUL MERCANTILE PVT LTD Entities with joint control or significant influence over entity Interest paid Approved by Audit Committee 36.38 0.00 16.83
7 Rama Phosphates Limited Rainbow Agri Industries Ltd. Entities with joint control or significant influence over entity Any other transaction Receiving of Services (Rent Paid) Approved by Audit Committee 54.00 0.00 0.00
8 Rama Phosphates Limited Haresh Ramsinghani Key management personnel of entity Remuneration Approved by Audit Committee 95.48 0.00 0.00
9 Rama Phosphates Limited Jambu Kumar Parakh Key management personnel of entity Remuneration Approved by Audit Committee 88.81 0.00 0.00
10 Rama Phosphates Limited Bhavna Dave Key management personnel of entity Remuneration Approved by Audit Committee 5.32 0.00 0.00
11 Rama Phosphates Limited Nilanjana H Ramsinghani Director Any other transaction Sitting Fees Paid Approved by Audit Committee 0.30 0.00 0.00
12 Rama Phosphates Limited Naresh Verma Director Any other transaction Sitting Fees Paid Approved by Audit Committee 0.30 0.00 0.00
13 Rama Phosphates Limited Brij Lal Khanna Director Any other transaction Sitting Fees Paid Approved by Audit Committee 0.75 0.00 0.00
14 Rama Phosphates Limited Kishore P Sukhthankar Director Any other transaction Sitting Fees Paid Approved by Audit Committee 0.45 0.00 0.00
15 Rama Phosphates Limited Pushpangadan Mangari Director Any other transaction Sitting Fees Paid Approved by Audit Committee 0.45 0.00 0.00
16 Rama Phosphates Limited Ratneshwar Prasad Director Any other transaction Sitting Fees Paid Approved by Audit Committee 0.60 0.00 0.00
17 RAMA PHOSPHATES LIMITED RAINBOW AGRI INDUSTRIES LIMITED Entities with joint control or significant influence over entity Any other transaction Security Deposit Approved by Audit Committee 0.00 50.00 50.00
18 RAMA PHOSPHATES LIMITED TRISHUL MERCANTILE PVT. LTD. Entities with joint control or significant influence over entity Sale of goods or services 7,437.00 Approved by Audit Committee 7,437.00 14-01-2026 5.03 0.00 0.00 Textual Information(1)
19 RAMA PHOSPHATES LIMITED RAMA PETROCHEMICALS LTD Entities with joint control or significant influence over entity Purchase of goods or services 7,437.00 Approved by Audit Committe 7,437.00 14-01-2026 81.52 0.00 0.00 Textual Information(2)
20 RAMA PHOSPHATES LIMITED RAMA CAPITAL & FISCAL SERVICES LTD. Entities with joint control or significant influence over entity Purchase of goods or services 7,437.00 Approved by Audit Committee 7,437.00 14-01-2026 25.39 0.00 26.66 Textual Information(3)
21 RAMA PHOSPHATES LIMITED Trishul Mercantile Pvt. Ltd. Entities with joint control or significant influence over entity Purchase of goods or services 7,437.00 Approved by Audit Committee 7,437.00 14-01-2026 0.00 (20.49) (20.49) Textual Information(4)
Total value of transaction during the reporting period 3,360.92



Text Block

Textual Information(1) Every year fresh approval is taken
Textual Information(2) Every year fresh approval is taken
Textual Information(3) Every year fresh approval is taken
Textual Information(4) Every year fresh approval is taken